PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2
J. Clin. Invest. Dailing Mao, et al. 116:2869
doi:10.1172/JCI28775 [Go to this article.]

Figure 5
PLCγ2 modulates RANKL-mediated signaling. (A) Activation of ERK and JNK in WT and Plcg2–/– BMMs in response to M-CSF (100 ng/ml). PLCγ1 and PLCγ2 levels are shown. (B) Western blot analysis of phospho-ERK, phospho-JNK, phospho–c-Jun, and phospho-IκBα in total cell lysates from WT and Plcg2–/– BMMs stimulated with RANKL (100 ng/ml) for the indicated times. β-Actin blots served as loading control for A and B. (C) Nuclear levels of phospho–c-Jun and p65 in nuclear extracts from WT and Plcg2–/– BMMs stimulated with RANKL. (D) The same samples used in C were subjected to AP1 and NF-κB nonradioactive EMSA analysis. To control for binding specificity, a concentration of unlabeled oligonucleotides (U.O.) 200-fold greater than that recommended by the manufacturer was added to nuclear extracts from WT cells stimulated with RANKL for 60 minutes. SP1 served as loading control for C and D.